These findings quantitatively demonstrated that recombinant adenovirus-mediated HCA661 expression in DCs not only elicited a potent, antigen-specific immune response but also substantially enhanced CTL-mediated killing of HCC cells. Here, TFDP3 is linked to hepatocellular carcinoma.